Q1 2025 Nuwellis Inc Earnings Call Transcript
Key Points
- Nuwellis Inc (NUWE) reported a 3% year-over-year increase in revenue for Q1 2025, driven by a 4% increase in consumables utilization and higher US console sales.
- Pediatric and heart failure segments showed significant growth, with revenues increasing by 38% and 28% respectively, compared to the previous year.
- The company has made progress in reimbursement coverage, with Aquadex therapy receiving a new outpatient reimbursement level from CMS, increasing the facility reimbursement fee by nearly four times.
- Nuwellis Inc (NUWE) has reduced operating expenses by 31% compared to Q1 2024, reflecting disciplined expense management.
- The company is expanding its outpatient strategy, targeting a $773 million market opportunity, which is expected to drive future top-line growth.
- Critical care sales decreased by 25% year-over-year, primarily due to a large customer acquiring excess inventory in the previous quarter.
- Gross margin declined to 56% from 64.1% in the same period last year, affected by unfavorable manufacturing variances and lower fixed overhead absorption.
- International sales decreased, partially offsetting the growth in US sales.
- The company ended the quarter with $2.6 million in cash and cash equivalents, indicating limited liquidity.
- Nuwellis Inc (NUWE) is still in the process of addressing logistical challenges for implementing outpatient clinics, which may delay revenue growth in this segment.
Good day, everyone, and welcome to Nuwellis first quarter 2025 earnings conference call. (Operator Instructions) Please note, this call is being recorded, and I will be standing by should you need any assistance.
It is now my pleasure to turn today's program over to Louisa Smith with Investor Relations.
Thank you, operator, and thank you for joining today's conference call to discuss Nuwellis' corporate developments and financial results for the first quarter ended March 31, 2025. In addition to myself, with us today on the call are John Erb, Nuwellis' Chairman of the Board and Interim CEO; and Rob Scott, Chief Financial Officer. At 8 AM Eastern Time today, Nuwellis released financial results for the first quarter of 2025. If you have not received Nuwellis' earnings release, please visit the Investors page on the company's website.
During this conference call, the company will be making forward-looking statements. All forward-looking statements made during today's call will be protected
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
